Michael Smith
MedPage Today
Toronto, ON, Canada
Contact Michael
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Michael:
HIV Cure Remains Elusive
Researchers face high bar for useful interventions → Read More
HIV: The Kids Aren't All Right
Study suggests infection numbers could rise sharply → Read More
HIV Increases Heart Failure Risk
Study adds to evidence but mechanism remains unclear → Read More
Hot Chemo Fails in Rare Cancer
HIPEC and surgery equals surgery alone in peritoneal carcinomatosis → Read More
Genetic Test Can Rule Out Chemo Use in Early Breast Cancer
Most women can get endocrine therapy alone based on Oncotype Dx results → Read More
PI3K Inhibitor Has Mixed Results in Advanced Breast Cancer
Modest progression benefit, but substantial side effects, with taselisib → Read More
Black Patients Actually Do Well in Prostate Cancer Trials
Outcomes as good as in white patients, and contrast with dismal record in clinical practice → Read More
Zika Babies Born Normal Stay Normal
TORONTO -- Babies exposed to Zika virus in utero but who are born with normal neuroimaging appear to develop in much the same way as do unexposed infants, a researcher said here. At 6 months of age, the infants had neuromotor skills similar to those of unexposed controls, according to Sarah Mulkey, MD, of Children's National Health System in Bethesda, Md. And a difference seen on one test is… → Read More
U.S. Life Expectancy Falls Again
Life expectancy at birth in the U.S. fell slightly in 2016 -- to 78.6 years from 78.7 years in 2015, according to the CDC's National Center for Health Statistics (NCHS). The changes are the first consecutive declines in life expectancy at birth since the early 1960s, the CDC said, and they come 3 years after the record high of 78.8 years. They also come after a statistical analysis earlier this… → Read More
HIV Vax Trial Teaches Lessons
Placebo control still has important place in clinical research → Read More
World AIDS Day Picture Mixed
Researchers note major progress, looming challenges → Read More
WHO: Cut Antibiotic Use in Food Animals
Guidelines would ban growth promotion with antimicrobials → Read More
Asthma Death Rate Falling in U.S.
Change over time driven by fewer asthma deaths among seniors → Read More
Flu Vax May Improve Outcomes in Other Illnesses
Vaccinated patients hospitalized with flu had lower risk of AKI development → Read More
Experts Raise Red Flag over Fatty Liver Disease
Paints gloomy picture for population health, economy → Read More
AASLD Liver Meeting Covers a Lot of Ground
WASHINGTON -- The annual Liver Meeting always draws a crowd, largely because there's pretty much something for everyone with an interest in hepatology. "We don't have a specific theme because we have to cover every aspect of liver development," according to Anna Lok, MD, of the University of Michigan in Ann Arbor, president of the American Association for Liver Diseases, which sponsors the… → Read More
Ebola Vaccines Safe, Yield Immune Responses
* Two vaccines against Ebola, tested as the 2013-2016 West African outbreak was declining, were safe and immunogenic. * Several editors of the journal called for the scientific community to work out ways to conduct reliable research in the trenches -- before a new outbreak occurs. Two vaccines against Ebola, tested as the 2013-2016 West African outbreak was declining, were safe and immunogenic,… → Read More
Efficacy Maintained in HIV Regimen Switch
* Note that this study was published as an abstract and presented at a conference. These data and conclusions should be considered to be preliminary until published in a peer-reviewed journal. * Note that this randomized trial of patients with HIV on protease-inhibitor based therapy found that switching to a single-pill bictegravir/emtricitabine/tenofovir regimen was non-inferior to remaining on… → Read More
Pneumococcal Disease Rates Dropped After Vax Introduction
* Note that this study was published as an abstract and presented at a conference. These data and conclusions should be considered to be preliminary until published in a peer-reviewed journal. * Note that this epidemiologic study found that rates of invasive pneumococcal disease fell after the introduction of the 13-valent Pneumococcal Conjugate Vaccine. * Be aware that non-vaccine serotype… → Read More
Investigational Flu Drug a Near Match for Oseltamivir
Clinical outcomes 'identical' but virology different → Read More